MMTG AEGES ESCort-GC研究(サルベージ試験)
COMPASS-D プロシュア HANGESHA-G
SAMIT試験・付随研究 CTコロノグラフィー
FLEX study PPG サルコぺニア試験 E-SPOG Phantom試験
横須賀胃がんリスク検診
Matsuoka M, et al., Efficacy of Risk-Stratified Screening for Gastric Cancer: A Retrospective Repeated Cross-Sectional Study in Yokosuka, Japan. Journal of Gastrointestinal & Digestive System, 12:12 (2022).
T. Oshima et al., Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial. Oncotarget
11, 2906-2918 (2020).
T. Oshima et al., Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. Sci Rep 12, 8509 (2022).
R. Sundar et al., Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. Gut 71, 676-685 (2022).
A. Tsuburaya et al., Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials. Gastric Cancer 24, 1184-1193 (2021).